Tevogen (TVGN) Restructuring Costs (2024)
Tevogen's (TVGN) quarterly Restructuring Costs came in at $7.5 million in Q1 2024.
Powered by 
Analysis
Tevogen (TVGN) Restructuring Costs (2024) Analysis & Trends
Tevogen (TVGN) has reported Restructuring Costs for 1 consecutive years, with $7.5 million the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Restructuring Costs changed N/A year-over-year to $7.5 million; the trailing twelve-month figure through Dec 2024 stood at $7.5 million (changed N/A YoY), and the FY2024 full-year result was $7.5 million, changed N/A from the prior year.
- Restructuring Costs steadied at $7.5 million in Q1 2024 per TVGN's latest filing.
- Across five years, Restructuring Costs topped out at $7.5 million in Q1 2024 and bottomed at $7.5 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.36 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tevogen | 26.95 Mn | 26.95 Mn | - |